DIFFERENTIAL EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS TYPE-1 INHIBITOR DURING HEALING OF MOUSE SKIN WOUNDS

被引:149
作者
ROMER, J
LUND, LR
ERIKSEN, J
RALFKIAER, E
ZEHEB, R
GELEHRTER, TD
DANO, K
KRISTENSEN, P
机构
[1] RIGSHOSP, DEPT PATHOL, DK-2100 COPENHAGEN, DENMARK
[2] UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA
关键词
D O I
10.1111/1523-1747.ep12486833
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The expression of urokinase-type plasminogen activator (u-PA) and its type-1 inhibitor (PAI-1) was examined in vivo in mouse wounds by in situ hybridization and immunohistochemistry. u-PA mRNA was present in both basal and suprabasal keratinocytes in the regenerative epithelial outgrowths at the edge of the wounds. In the same area, PAI-1 mRNA was only present in the basal keratinocytes. u-PA protein was detected in keratinocytes in several layers of the epithelial outgrowth, whereas PAI-1 protein was confined to the basal keratinocytes and to the area of the basal membrane. The two proteins and their mRNA were not detected in normal epidermis or in normal-looking epidermis adjacent to the wounds. Fibroblast-like cells and fairly large stellate cells (possibly macrophages) in the granulation tissue underneath the wound contained both the two proteins and their mRNA. The large stellate cells, showing a strong hybridization signal for PAI-1 mRNA, were especially abundant at the border between the necrotic wound and the newly formed granulation tissue. The specificity of these results was supported by the use of two different non-overlapping antisense probes, sense mRNA probes, antibody preparations preabsorbed with purified proteins, and Northern analysis of tissue extracts. The localized and regulated expression of u-PA and PAI-1 seen in this study may reflect that plasminogen activation plays a role in the migration of keratinocytes and connective tissue cells during reepithelialization and tissue remodeling in wound healing.
引用
收藏
页码:803 / 811
页数:9
相关论文
共 64 条
[21]   UROKINASE-TYPE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS IN KERATINOCYTES DURING WOUND REEPITHELIALIZATION INVIVO [J].
GRONDAHLHANSEN, J ;
LUND, LR ;
RALFKIAER, E ;
OTTEVANGER, V ;
DANO, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 90 (06) :790-795
[22]   CHARACTERIZATION OF KERATINOCYTE PLASMINOGEN-ACTIVATOR INHIBITORS AND DEMONSTRATION OF THE PREVENTION OF PEMPHIGUS IGG-INDUCED ACANTHOLYSIS BY A PURIFIED PLASMINOGEN-ACTIVATOR INHIBITOR [J].
HASHIMOTO, K ;
WUN, TC ;
BAIRD, J ;
LAZARUS, GS ;
JENSEN, PJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) :310-315
[23]   GLUCOCORTICOID INDUCTION OF PLASMINOGEN-ACTIVATOR AND PLASMINOGEN ACTIVATOR-INHIBITOR MESSENGER-RNA IN RAT HEPATOMA-CELLS [J].
HEATON, JH ;
GELEHRTER, TD .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (02) :349-355
[24]   LINKAGE OF EXTRACELLULAR PLASMINOGEN-ACTIVATOR TO THE FIBROBLAST CYSTOSKELETON - COLOCALIZATION OF CELL-SURFACE UROKINASE WITH VINCULIN [J].
HEBERT, CA ;
BAKER, JB .
JOURNAL OF CELL BIOLOGY, 1988, 106 (04) :1241-1247
[25]   PLASMINOGEN-ACTIVATOR IN DIFFERENTIATING MOUSE KERATINOCYTES [J].
ISSEROFF, RR ;
FUSENIG, NE ;
RIFKIN, DB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 80 (04) :217-222
[26]   PLASMINOGEN-ACTIVATOR INHIBITOR-TYPE-1 IN LEWIS LUNG-CARCINOMA [J].
KRISTENSEN, P ;
PYKE, C ;
LUND, LR ;
ANDREASEN, PA ;
DANO, K .
HISTOCHEMISTRY, 1990, 93 (06) :559-566
[27]   IMMUNOCYTOCHEMICAL DEMONSTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ENDOCRINE-CELLS OF THE RAT PITUITARY-GLAND [J].
KRISTENSEN, P ;
NIELSEN, LS ;
GRONDAHLHANSEN, J ;
ANDRESEN, PB ;
LARSSON, LI ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1985, 101 (01) :305-311
[28]  
KRISTENSEN P, IN PRESS J HISTOCHEM
[29]  
KRUITHOF EKO, 1986, THROMB HAEMOSTASIS, V55, P201
[30]  
LAIHO M, 1989, CANCER RES, V49, P2533